- Home
- IQI
as 07-26-2024 4:00pm EST
Invesco Quality Municipal Income Trust is a diversified, closed-end management investment company. Its investment objective is to provide current income which is exempt from federal income tax.
| Founded: | 1992 | Country: | United States |
| Employees: | N/A | City: | N/A |
| Market Cap: | 540.5M | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 162.1K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | Dividend Payout Frequency: | Monthly | |
| EPS: | -0.01 | EPS Growth: | N/A |
| 52 Week Low/High: | $8.05 - $10.00 | Next Earning Date: | 01-01-0001 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Invesco Quality Municipal Income Trust News
IQI Breaking Stock News: Dive into IQI Ticker-Specific Updates for Smart Investing
PR Newswire
25 days ago
Invesco Closed-End Funds Announce Increased Distribution Rates for All Investment Grade Municipal Bond Closed-End Funds and Declare Dividends
PR Newswire
2 months ago
Invesco Closed-End Funds Announce Increased Distribution Rates for All Investment Grade Municipal Bond Closed-End Funds and Declare Dividends
PR Newswire
3 months ago
Invesco Closed-End Funds Declare Dividends
PR Newswire
4 months ago
Invesco Closed-End Funds Declare Dividends
PR Newswire
5 months ago
Invesco Closed-End Funds Declare Dividends
Simply Wall St.
6 months ago
Calculating The Fair Value Of Pitney Bowes Inc. (NYSE:PBI)
PR Newswire
6 months ago
Tyra Biosciences, Inc. Announces $200 Million Private Placement Financing
PR Newswire
6 months ago
Tyra Biosciences Receives FDA Rare Pediatric Disease Designation for TYRA-300 for the Treatment of Achondroplasia
Compare IQI vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "IQI Invesco Quality Municipal Income Trust - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.